Ring Christine
Reporting owner on Forms 3, 4 and 5, CIK 1817199.
Ring Christine reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-02.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Nurix Therapeutics, Inc. CIK 1549595 | officer (Chief Legal Officer) | 1 | 2026-10-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Nurix Therapeutics, Inc. Common Stock | 2026-10-02 | M exercised | +5,786 | $8.72 | 14,896 | Form 4 |
| Nurix Therapeutics, Inc. Common Stock | 2026-10-02 | S sold | -5,786 | $23.1851 | 9,110 | Form 4 |
| Nurix Therapeutics, Inc. Employee Stock Option (right to buy), derivative | 2026-10-02 | M exercised | -5,786 | $0 | 111,251 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001817199-26-000032 | Nurix Therapeutics, Inc. | 2026-10-02 |